LAVAL, Quebec, Oct. 3, 2013 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that its wholly owned subsidiary, Valeant Canada LP, has received notice that the New Drug Submission for Jublia® has been approved from the Canadian regulatory authority, Health Canada. Jublia® (efinaconazole 10% topical solution) is indicated for the […]
Stockholm, October 2 – Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment. The system relies on a small […]
Holzkirchen, Germany, October 02, 2013 – The European Generic medicines Association (EGA) has named Sandoz’s Nick Haggar as the new incoming president of the European generic medicines industry body. Nick will take over the role on October 8, 2013 alongside his responsibilities at Sandoz as Head of Western Europe, Middle East and Africa. “I am delighted […]
LAVAL, Quebec, Oct. 2, 2013 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced a partnership with the National Coalition Against Domestic Violence (NCADV) to help raise awareness of domestic violence. As part of the new domestic violence initiative, Valeant has pledged to donate a portion of sales from all Medicis and […]
Data Support Strong Statistical Association of PBC Biochemical Endpoint with Clinical Outcomes NEW YORK, Oct. 1, 2013 /PRNewswire/ — Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)(Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases such as primary biliary cirrhosis, today announced that two analyses by the Global Primary Biliary Cirrhosis (PBC) […]
WASHINGTON, Sept. 24, 2013 /PRNewswire/ — As Medicare and Medicaid brace for a continued influx of beneficiaries – many of whom are older and more likely to have chronic conditions including cancer – all players across the continuum of care need to work together, now, to implement innovative new care delivery models that can improve […]
Pilot Program Cuts Time for Clinicians to Obtain Supplies Nearly in Half DUBLIN, Ohio, Sept. 24, 2013 — Cardinal Health today unveiled its 2-Bin Kanban solution, an innovative approach to inventory management, at the Fall IDN Summit and Reverse Expo in Phoenix. The Cardinal Health 2-Bin Kanban solution combines principles of the Lean Six Sigma […]
Learning and Innovation Center (LINC) to draw thousands to Atlanta ATLANTA, Sept. 23 – Elekta will unveil a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. The Learning and Innovation Center (LINC) is expected to draw […]
ATLANTA, US, September 23 – Elekta’s strategy to be number one in the radiation therapy industry is built on developing advanced products, software and services, which will continue to drive strong growth, according to President and CEO, Tomas Puusepp. He spoke today at the Elekta Capital Markets Day in Atlanta, Georgia during the 55th Annual […]
Offers Surgeons Enhanced Imaging During Minimally Invasive Robotic-Assisted Procedures SUNNYVALE, Calif., Sept. 23, 2013 (GLOBE NEWSWIRE) — Intuitive Surgical, Inc. (Nasdaq:ISRG), the global leader in minimally invasive robotic-assisted surgery, today announced it received FDA 510(k) clearance for expanded use of its da Vinci® Fluorescence Imaging Vision System (Firefly™) for the da Vinci® Surgical System. Firefly imaging can now be used during gallbladder surgery. The Firefly Fluorescence Imaging Vision System enables surgeons to use […]